sanofi vigil neuroscience - Search News

Order byBest matchMost fresh

News

Sanofi buys Vigil Neuroscience for $470m

Sanofi to buy Vigil Neuroscience in $470M deal (update)

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) for $470M in cash, potentially reaching $600M with milestone payments. Following a trading halt,

Continue reading

· 2d · on MSN

· 2d · on MSN

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

Fierce Biotech3d

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results